Prometheus Biosciences, Inc. — Form D

Prometheus Biosciences, Inc. of San Diego, CA, a company, filed a Form D exempt-offering notice with the SEC on 2017-10-10. The offering totals $10.0M, of which $3.7M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (43)

Showing 25 of 43 people.

NameRoleLocation
Lauren OtsukiExecutive OfficerSan Diego, CA
Shierley WidjajaDirectorSan Diego, CA
Douglas F WallDirectorRancho Santa Fe, CA
James LaurDirectorRaleigh, NC
Douglas WallDirectorPoway, CA
Scott L GlennDirectorBoulder, CO
Scott L GlennExecutive OfficerBoulder, CO
Shlomo MelmedDirectorSan Jose, CA
Tadataka Yamada, M.D.DirectorSeattle, WA
Joy Ghosh, Ph.D.DirectorSan Diego, CA
Martin Hendrix, Ph.D.DirectorSan Diego, CA
James D LaurDirectorSan Diego, CA
Joseph C PapaDirectorSan Diego, CA
William C Sandborn, M.D.DirectorSan Diego, CA
Adam C StoneDirectorSan Diego, CA
Shierley C WidjajaDirectorSan Diego, CA
Tadataka Tachi Yamada, M.D.DirectorSan Diego, CA
Mark Tachi McKennaDirectorSan Diego, CA
Mark Tachi McKennaExecutive OfficerSan Diego, CA
Keith W Marshall, Ph.D.Executive OfficerSan Diego, CA
Laurens W Kruidenier, Ph.D.Executive OfficerSan Diego, CA
Allison W Luo, M.D.Executive OfficerSan Diego, CA
Lauren G OtsukiExecutive OfficerSan Diego, CA
GREGORY BEHARDirectorSAN DIEGO, CA
MARK MCKENNADirectorSAN DIEGO, CA

Other filings by this issuer (4)

FiledFormOfferingSold
2020-11-12D$130.0M$50.0M
2020-04-10D/A$60.0M$48.1M
2019-07-15D$50.0M$20.0M
2018-11-28D$20.0M$10.1M

More